Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Kailera jumped the weight loss miracle-drug line by licensing four clinical-stage obesity therapies from China, which is ...

Next on the list of largest golden parachutes is Gilead’s Daniel O’Day, who would receive $80.6 million in the event of ...

Roche has pledged to build a giant weight-loss drug factory in the US. The plans form part of a $50bn (£37bn) pledge aimed at ...

A unique Novo Nordisk legal challenge to the Medicare drug pricing program could have big implications for the pharma ...

U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

Although the uncertainty took a bite out of Big Pharma stocks ... reduced reliance on foreign suppliers; major pharmaceutical companies making … U.S. expansions; and policy incentives with ...